P14867 GBRA1_HUMAN
Gene name: GABRA1
Protein name: Gamma-aminobutyric acid receptor subunit alpha-1
List of molecules and drugs that target protein P14867
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P14867_DB00241 | DB00241 | Butalbital | potentiator | UZVHFVZFNXBMQJ-UHFFFAOYSA-N | CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O | |
2 | P14867_DB00273 | DB00273 | Topiramate | agonist | KJADKKWYZYXHBB-XBWDGYHZSA-N | [H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2 | |
3 | P14867_DB00292 | DB00292 | Etomidate | agonist | IC50(nM) = 577000.0 EC50(nM) = 1200.0 | NPUKDXXFDDZOKR-LLVKDONJSA-N | CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 |
4 | P14867_DB00306 | DB00306 | Talbutal | potentiator | BJVVMKUXKQHWJK-UHFFFAOYSA-N | CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O | |
5 | P14867_DB00312 | DB00312 | Pentobarbital | potentiator | IC50(nM) = 1000000.0 | WEXRUCMBJFQVBZ-UHFFFAOYSA-N | CCCC(C)C1(CC)C(=O)NC(=O)NC1=O |
6 | P14867_DB00371 | DB00371 | Meprobamate | agonist | NPPQSCRMBWNHMW-UHFFFAOYSA-N | CCCC(C)(COC(N)=O)COC(N)=O | |
7 | P14867_DB00395 | DB00395 | Carisoprodol | activator | OFZCIYFFPZCNJE-UHFFFAOYSA-N | CCCC(C)(COC(N)=O)COC(=O)NC(C)C | |
8 | P14867_DB00402 | DB00402 | Eszopiclone | potentiator | GBBSUAFBMRNDJC-INIZCTEOSA-N | CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1 | |
9 | P14867_DB00418 | DB00418 | Secobarbital | potentiator | KQPKPCNLIDLUMF-UHFFFAOYSA-N | CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O | |
10 | P14867_DB00425 | DB00425 | Zolpidem | agonist | Ki(nM) = 15.5 IC50(nM) = 14.0 EC50(nM) = 191.0 | ZAFYATHCZYHLPB-UHFFFAOYSA-N | CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1 |
11 | P14867_DB00463 | DB00463 | Metharbital | potentiator | FWJKNZONDWOGMI-UHFFFAOYSA-N | CCC1(CC)C(=O)NC(=O)N(C)C1=O | |
12 | P14867_DB00466 | DB00466 | Picrotoxin | antagonist | VJKUPQSHOVKBCO-ZTYBEOBUSA-N | [H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O | |
13 | P14867_DB00474 | DB00474 | Methohexital | antagonist | NZXKDOXHBHYTKP-UHFFFAOYSA-N | CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O | |
14 | P14867_DB00543 | DB00543 | Amoxapine | antagonist | QWGDMFLQWFTERH-UHFFFAOYSA-N | ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1 | |
15 | P14867_DB00599 | DB00599 | Thiopental | potentiator | IUJDSEJGGMCXSG-UHFFFAOYSA-N | CCCC(C)C1(CC)C(=O)NC(=S)NC1=O | |
16 | P14867_DB00753 | DB00753 | Isoflurane | agonist | PIWKPBJCKXDKJR-UHFFFAOYSA-N | FC(F)OC(Cl)C(F)(F)F | |
17 | P14867_DB00794 | DB00794 | Primidone | potentiator | DQMZLTXERSFNPB-UHFFFAOYSA-N | CCC1(C(=O)NCNC1=O)C1=CC=CC=C1 | |
18 | P14867_DB00837 | DB00837 | Progabide | agonist | IBALRBWGSVJPAP-UHFFFAOYSA-N | OC(=N)CCCN=C(C1=CC=C(Cl)C=C1)C1=C(O)C=CC(F)=C1 | |
19 | P14867_DB00849 | DB00849 | Methylphenobarbital | potentiator | ALARQZQTBTVLJV-UHFFFAOYSA-N | CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1 | |
20 | P14867_DB00898 | DB00898 | Ethanol | agonist | LFQSCWFLJHTTHZ-UHFFFAOYSA-N | CCO | |
21 | P14867_DB00962 | DB00962 | Zaleplon | potentiator | EC50(nM) = 290.0 | HUNXMJYCHXQEGX-UHFFFAOYSA-N | CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N |
22 | P14867_DB01028 | DB01028 | Methoxyflurane | agonist | RFKMCNOHBTXSMU-UHFFFAOYSA-N | COC(F)(F)C(Cl)Cl | |
23 | P14867_DB01107 | DB01107 | Methyprylon | agonist | SIDLZWOQUZRBRU-UHFFFAOYSA-N | CCC1(CC)C(=O)NCC(C)C1=O | |
24 | P14867_DB01154 | DB01154 | Thiamylal | agonist | XLOMZPUITCYLMJ-UHFFFAOYSA-N | CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O | |
25 | P14867_DB01159 | DB01159 | Halothane | other/unknown | BCQZXOMGPXTTIC-UHFFFAOYSA-N | [H]C(Cl)(Br)C(F)(F)F | |
26 | P14867_DB01174 | DB01174 | Phenobarbital | potentiator | DDBREPKUVSBGFI-UHFFFAOYSA-N | CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1 | |
27 | P14867_DB01198 | DB01198 | Zopiclone | potentiator | GBBSUAFBMRNDJC-UHFFFAOYSA-N | CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1 | |
28 | P14867_DB01205 | DB01205 | Flumazenil | antagonist | Ki(nM) = 0.48 | OFBIFZUFASYYRE-UHFFFAOYSA-N | CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1 |
29 | P14867_DB01346 | DB01346 | Quinidine barbiturate | potentiator | YHRUERMOPBDCFD-UHFFFAOYSA-N | CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C | |
30 | P14867_DB01351 | DB01351 | Amobarbital | potentiator | VIROVYVQCGLCII-UHFFFAOYSA-N | CCC1(CCC(C)C)C(=O)NC(=O)NC1=O | |
31 | P14867_DB01352 | DB01352 | Aprobarbital | potentiator | UORJNBVJVRLXMQ-UHFFFAOYSA-N | CC(C)C1(CC=C)C(=O)NC(=O)NC1=O | |
32 | P14867_DB01353 | DB01353 | Butobarbital | potentiator | STDBAQMTJLUMFW-UHFFFAOYSA-N | CCCCC1(CC)C(=O)NC(=O)NC1=O | |
33 | P14867_DB01354 | DB01354 | Heptabarbital | potentiator | PAZQYDJGLKSCSI-UHFFFAOYSA-N | CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1 | |
34 | P14867_DB01355 | DB01355 | Hexobarbital | potentiator | UYXAWHWODHRRMR-UHFFFAOYSA-N | CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1 | |
35 | P14867_DB01437 | DB01437 | Glutethimide | agonist | JMBQKKAJIKAWKF-UHFFFAOYSA-N | CCC1(CCC(=O)NC1=O)C1=CC=CC=C1 | |
36 | P14867_DB01483 | DB01483 | Barbital | potentiator | FTOAOBMCPZCFFF-UHFFFAOYSA-N | CCC1(CC)C(=O)NC(=O)NC1=O | |
37 | P14867_DB01496 | DB01496 | Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione | potentiator | DNZPLHRZXUJATK-UHFFFAOYSA-N | FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1 | |
38 | P14867_DB01567 | DB01567 | Fludiazepam | potentiator | ROYOYTLGDLIGBX-UHFFFAOYSA-N | CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F | |
39 | P14867_DB06470 | DB06470 | Clomethiazole | n/a | PCLITLDOTJTVDJ-UHFFFAOYSA-N | CC1=C(CCCl)SC=N1 | |
40 | P14867_DB12458 | DB12458 | Muscimol | n/a | ZJQHPWUVQPJPQT-UHFFFAOYSA-N | NCC1=CC(=O)NO1 |